Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 04, 2019
Constellation (STZ, $187.09) beats fiscal Q4 earnings estimates, says cheers to beer

Constellation (STZ, $187.09) beats fiscal Q4 earnings estimates, says cheers to beer

Constellation Brands fiscal fourth quarter earnings surpassed analysts’ expectations, largely in part due to the beverage company’s beer sales. The company is also pulling out from its low-end wine brands, apparently to focus on better selling products.

Comparable earnings for the three months ending February came in at $1.84 per share, down -3.15% from the year-ago quarter, but higher than the Street estimate of $1.72 per share.

The company’s sales of $1.797 billion also beat analysts' estimates of $1.73 billion. Sales were also +2% higher compared to the year-ago period.

As it is, consumers are increasingly adopting healthier lifestyles and food habits. People who still consume alcohol are apparently preferring higher-quality wine or premium beer.  It is probably this shift in consumer choices that has led Constellation to re-allocate its business more towards beer and other high-end beverages.

On Wednesday, Constellation announced plans to sell off about 30 brands from its wine and spirits portfolio to E. & J. Gallo Winery for $1.7 billion. The company will also be launching its first ever non-beer beverage, named Corona Refresca, during its first quarter.

For the latest reported quarter, Constellation’s beer sales climbed +9.3% year-over-year to $1.09 billion. According to the company, its beer business was the top U.S. market share gainer during the holiday season. It mentioned its brands Modelo Especial, Corona Premier and Corona Familiar as major contributors to its solid beer sales.

Sales from its wine and spirits segment, on the other hand, plunged -7.6% year-over-year to $707.1 million. 

For fiscal full-year 2020, Constellation forecasts that its comparable earnings would  range between $8.50 and $8.80 per share, excluding Canopy Growth equity earnings (Constellation bought a 38% stake in the marijuana company last year, as a sign of its plans to expand footprints in the cannabis space). The company hopes to have a 7%-9% growth in operating income from its beer division, while anticipating wine and spirits to be hit by -30% to -35% decline in operating incomes.

 

 

Related Ticker: STZ

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


STZ in downward trend: 10-day moving average moved below 50-day moving average on August 28, 2026

The 10-day moving average for STZ crossed bearishly below the 50-day moving average on August 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STZ as a result. In 48 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 52%.

The Moving Average Convergence Divergence Histogram (MACD) for STZ turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 21 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.

STZ moved below its 50-day moving average on August 27, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

The Aroon Indicator for STZ entered a downward trend on September 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STZ's RSI Oscillator exited the oversold zone, 20 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where STZ advanced for three days, in 158 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.

STZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.545) is normal, around the industry mean (2.110). P/E Ratio (11.717) is within average values for comparable stocks, (17.084). Projected Growth (PEG Ratio) (1.564) is also within normal values, averaging (2.425). Dividend Yield (0.033) settles around the average of (0.038) among similar stocks. P/S Ratio (2.366) is also within normal values, averaging (1.539).

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. STZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are Anheuser-Busch INBEV SA/NV (NYSE:BUD), Constellation Brands (NYSE:STZ), Molson Coors Beverage Company (NYSE:TAP).

Industry description

The meat, fish, and dairy food industry processes livestock, fish and milk products for consumer consumption. Some companies also process dairy byproducts. Tyson Foods, Inc., Hormel Foods Corporation and Pilgrims Pride Corp. are some of the biggest producers in this industry. Many of these companies are recipients of American farm subsidies. On the other hand, new-age food innovation like plant-based meat substitutes (which are designed to simulate chicken, beef, and pork sausage) could potentially augur disruptions and/or create new competition in this space.

Market Cap

The average market capitalization across the Food: Meat/Fish/Dairy Industry is 39.62B. The market cap for tickers in the group ranges from 317.04K to 156.85B. BUD holds the highest valuation in this group at 156.85B. The lowest valued company is ENHD at 317.04K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Meat/Fish/Dairy Industry was 0%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 2%. SAM experienced the highest price growth at 5%, while CCU experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Food: Meat/Fish/Dairy Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 24
P/E Growth Rating: 57
Price Growth Rating: 56
SMR Rating: 60
Profit Risk Rating: 75
Seasonality Score: -42 (-100 ... +100)
Related Portfolios: CONSUMER STAPLES ETFs
View a ticker or compare two or three
STZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an alcoholic beverages distributor

Industry FoodMeatFishDairy

Profile
Details
Industry
Beverages Alcoholic
Address
50 East Broad Street
Phone
+1 585 678-7100
Employees
9400
Web
https://www.cbrands.com
Interact to see
Advertisement
Shares of NSA stock surged roughly 27% in premarket trading after the company agreed to be acquired by Public Storage in an all-stock transaction valued at about $10.5 billion. The deal values National Storage Affiliates at an implied price of about $41.68 per share, representing a substantial premium to its prior closing price near the low-$30s.
Shares of NBIS jumped roughly 12% in premarket trading after a sharp rally in the prior regular session. The latest leg of the price rally follows news of a multibillion‑dollar, long‑term AI infrastructure agreement with Meta Platforms that expands Nebius’s cloud capacity commitments.
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Constellation (STZ, $187.09) beats fiscal Q4 earnings estimates, says cheers to beer